A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension

H-1337 - D. Western Therapeutics Institute

timolol maleate ophthalmic solution - Generic mfg.

Robert D. Williams1; Jay Mulaney2; Jennifer Beck1; Jeanette Stewart1; Gary D. Novack3,4

Mar 26, 2025